QQQ   424.06 (-0.42%)
AAPL   167.20 (-0.48%)
MSFT   405.19 (-1.61%)
META   503.38 (+1.86%)
GOOGL   156.45 (+0.63%)
AMZN   179.55 (-0.95%)
TSLA   150.45 (-3.22%)
NVDA   849.20 (+1.05%)
AMD   154.94 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.96 (+0.20%)
T   16.31 (+1.18%)
F   12.05 (+0.08%)
MU   112.52 (-3.28%)
GE   153.77 (-1.22%)
CGC   7.87 (+21.26%)
DIS   112.76 (-0.16%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.08 (-1.87%)
XOM   118.72 (+0.08%)
QQQ   424.06 (-0.42%)
AAPL   167.20 (-0.48%)
MSFT   405.19 (-1.61%)
META   503.38 (+1.86%)
GOOGL   156.45 (+0.63%)
AMZN   179.55 (-0.95%)
TSLA   150.45 (-3.22%)
NVDA   849.20 (+1.05%)
AMD   154.94 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.96 (+0.20%)
T   16.31 (+1.18%)
F   12.05 (+0.08%)
MU   112.52 (-3.28%)
GE   153.77 (-1.22%)
CGC   7.87 (+21.26%)
DIS   112.76 (-0.16%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.08 (-1.87%)
XOM   118.72 (+0.08%)
QQQ   424.06 (-0.42%)
AAPL   167.20 (-0.48%)
MSFT   405.19 (-1.61%)
META   503.38 (+1.86%)
GOOGL   156.45 (+0.63%)
AMZN   179.55 (-0.95%)
TSLA   150.45 (-3.22%)
NVDA   849.20 (+1.05%)
AMD   154.94 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.96 (+0.20%)
T   16.31 (+1.18%)
F   12.05 (+0.08%)
MU   112.52 (-3.28%)
GE   153.77 (-1.22%)
CGC   7.87 (+21.26%)
DIS   112.76 (-0.16%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.08 (-1.87%)
XOM   118.72 (+0.08%)
QQQ   424.06 (-0.42%)
AAPL   167.20 (-0.48%)
MSFT   405.19 (-1.61%)
META   503.38 (+1.86%)
GOOGL   156.45 (+0.63%)
AMZN   179.55 (-0.95%)
TSLA   150.45 (-3.22%)
NVDA   849.20 (+1.05%)
AMD   154.94 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.96 (+0.20%)
T   16.31 (+1.18%)
F   12.05 (+0.08%)
MU   112.52 (-3.28%)
GE   153.77 (-1.22%)
CGC   7.87 (+21.26%)
DIS   112.76 (-0.16%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.08 (-1.87%)
XOM   118.72 (+0.08%)
NASDAQ:TSVT

2seventy bio (TSVT) Stock Price, News & Analysis

$4.63
-0.43 (-8.50%)
(As of 03:52 PM ET)
Today's Range
$4.61
$5.07
50-Day Range
$3.96
$6.00
52-Week Range
$1.53
$12.69
Volume
575,965 shs
Average Volume
1.41 million shs
Market Capitalization
$237.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.17

2seventy bio MarketRank™ Stock Analysis

Analyst Rating
Hold
2.38 Rating Score
Upside/​Downside
185.0% Upside
$13.17 Price Target
Short Interest
Bearish
14.29% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.89mentions of 2seventy bio in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
$3.14 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($1.39) to $0.07 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.50 out of 5 stars

Medical Sector

272nd out of 914 stocks

Pharmaceutical Preparations Industry

109th out of 413 stocks

TSVT stock logo

About 2seventy bio Stock (NASDAQ:TSVT)

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

TSVT Stock Price History

TSVT Stock News Headlines

Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
2seventy bio Inc Ordinary Shares
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Bristol Myers Wins FDA Nod for Abecma
See More Headlines
Receive TSVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 2seventy bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2024
Today
4/18/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TSVT
Fax
N/A
Employees
274
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.17
High Stock Price Target
$26.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+160.2%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
8 Analysts

Profitability

Net Income
$-217,570,000.00
Net Margins
-216.73%
Pretax Margin
-216.73%

Debt

Sales & Book Value

Annual Sales
$100.39 million
Book Value
$5.04 per share

Miscellaneous

Free Float
49,977,000
Market Cap
$259.63 million
Optionable
Optionable
Beta
1.84
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives


TSVT Stock Analysis - Frequently Asked Questions

Should I buy or sell 2seventy bio stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for 2seventy bio in the last year. There are currently 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TSVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TSVT, but not buy additional shares or sell existing shares.
View TSVT analyst ratings
or view top-rated stocks.

What is 2seventy bio's stock price target for 2024?

8 Wall Street research analysts have issued twelve-month price objectives for 2seventy bio's shares. Their TSVT share price targets range from $5.00 to $26.00. On average, they anticipate the company's stock price to reach $13.17 in the next year. This suggests a possible upside of 185.0% from the stock's current price.
View analysts price targets for TSVT
or view top-rated stocks among Wall Street analysts.

How have TSVT shares performed in 2024?

2seventy bio's stock was trading at $4.27 at the start of the year. Since then, TSVT shares have increased by 8.2% and is now trading at $4.62.
View the best growth stocks for 2024 here
.

Are investors shorting 2seventy bio?

2seventy bio saw a increase in short interest in March. As of March 31st, there was short interest totaling 6,810,000 shares, an increase of 29.7% from the March 15th total of 5,250,000 shares. Based on an average daily trading volume, of 1,450,000 shares, the short-interest ratio is presently 4.7 days. Approximately 14.3% of the shares of the stock are short sold.
View 2seventy bio's Short Interest
.

When is 2seventy bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our TSVT earnings forecast
.

How were 2seventy bio's earnings last quarter?

2seventy bio, Inc. (NASDAQ:TSVT) posted its quarterly earnings data on Tuesday, March, 5th. The company reported ($1.11) EPS for the quarter, topping analysts' consensus estimates of ($1.22) by $0.11. The company had revenue of $10.68 million for the quarter, compared to the consensus estimate of $13.91 million. 2seventy bio had a negative trailing twelve-month return on equity of 59.19% and a negative net margin of 216.73%. During the same quarter in the prior year, the company posted ($0.60) EPS.

What ETFs hold 2seventy bio's stock?
Who are 2seventy bio's major shareholders?

2seventy bio's stock is owned by many different retail and institutional investors. Top institutional investors include Wedmont Private Capital (0.17%). Insiders that own company stock include Casdin Capital, Llc, Kynam Capital Management, Lp, Nick Leschly, Nicola Heffron, Philip D Gregory and William D Baird III.
View institutional ownership trends
.

How do I buy shares of 2seventy bio?

Shares of TSVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TSVT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners